Heart Disease Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Heart Disease
Research from University of Florence has provided new information about heart disease
July 6th, 2008
According to recent research from Florence, Italy, "The aim of this investigation was the assessment of the association of combined secretagogue/biguanide treatment with mortality in type 2 diabetic patients with and without ischemic heart disease (IHD). A retrospective observational cohort study was performed on a consecutive series of 1108 non insulin-treated diabetic outpatients, with a mean follow-up of 28.0 +/- 6.5 months." "Information on all-cause mortality was obtained by the City of Florence Registry Office. Patients treated with combinations of insulin secretagogues and biguanides at enrolment showed a significantly higher yearly mortality rate when compared...
Source: Heart Disease Weekly (2008-07-06)
|
